Masimo | MASI - Ativos





Ativos Alterar Data
Abbott USD 110.43B 23.72B 2026-03
Accuray USD 448.01M 8.81M 2025-12
Align Technology USD 6.31B 80.48M 2026-03
AngioDynamics USD 269.68M 4.04M 2025-09
Artivion USD 883.16M 1.64M 2026-03
AtriCure USD 643.99M 10.19M 2026-03
Avanos Medical USD 1.05B 23.6M 2026-03
Baxter International USD 19.85B 209M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Boston Scientific USD 44.35B 678M 2026-03
Dexcom USD 6.63B 293.4M 2026-03
Edwards Lifesciences USD 13.32B 376M 2026-03
General Electric Aerospace USD 128.45B 1.72B 2026-03
Globus Medical USD 5.44B 136.79M 2026-03
Haemonetics USD 2.4B 94.96M 2026-03
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 2.99B 203.2M 2026-03
Integra LifeSciences USD 3.58B 24.28M 2026-03
Intuitive Surgical USD 20.11B 347.7M 2026-03
Masimo USD 1.64B 56.2M 2026-03
Medtronic USD 91.48B 139M 2025-12
Orthofix International USD 886.6M 35.95M 2026-03
Owens Minor USD 2.42B 35.78M 2026-03
ResMed USD 8.78B 280.91M 2026-03
Steris USD 10.74B 145.8M 2026-03
Stryker USD 46.29B 1.55B 2026-03
Tandem Diabetes Care USD 1.15B 272.28M 2026-03
Teleflex USD 6.78B 164.24M 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03